ImmunityBio, Inc. — Director's Dealing 2020

Aug 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-08-02

Reporting Person: Nelson Sonja (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-02	Common Stock	M	10000	$0.00	Acquired	40410	Direct
2020-08-02	Common Stock	F	3458	$11.18	Disposed	36952	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-02	Restricted Stock Units	$	M	10000	Disposed		Common Stock (10000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of NantKwest, Inc. common stock.

F2: On August 2, 2020, 10,000 of the reporting person's restricted stock units vested. The closing price of the issuer's common stock on July 31, 2020 was the price used to calculate the shares withheld.

F3: Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 25% of the RSUs will vest on August 2, 2019, and 25% of the RSUs will vest annually thereafter, such that the award will be fully vested on August 2, 2022.